Mergers, spin-offs, buying, selling... news shows that global Big Pharmas have been busy constantly changing their shape.

In particular, the issue that gained the most attention for the past few years was the companies' spin-offs and sales. Although the companies' made the decision under the premise of ‘focusing on one’s strengths,’ such divisions and sales have brought out both positive and negative views. One thing to note is that these changes have been occurring 'serially' among global pharmaceutical companies.

◆Change in the development trend and surging investment cost = Although it is difficult to pinpoint the root cause of the constant change, a trend is evident.